Schedule 13D ownership disclosure

Corvus Pharmaceuticals Inc

Security class unavailable · CUSIP: 221015100

Event date: 2018-03-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
20.4700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-18-000247
Form type
SC 13D/A
Filer
Corvus Pharmaceuticals, Inc.
CIK
CIK 1626971
Filed
Mar 14, 2018
Reporting period
Mar 12, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub